Transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end of 2025
Nuvation Bio Inc., a late-stage,...
Company announces multi-year strategic partnership with AstraZeneca to accelerate early breast cancer evidence development and research.
PicnicHealth, a patient-centered health technology company, announced its entry...
New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to...
Catching cancer earlier and achieving more accurate initial diagnostics are two of the key benefits of breakthrough artificial intelligence technology that a European company...
BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, announced that it will continue clinical validation of a novel...
